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Abstract Cardiovascular magnetic resonance (CMR), a
valuable non-invasive technique for the evaluation of the
cardiovascular system, has already been accepted as
the "gold standard" for the assessment of systolic function.
The assessment of diastolic function is important not only
for diagnosis purposes, but also in terms of prognosis.
ECG-triggering phase-contrast (PC) CMR allows the
routine assessment of diastolic function by measuring the
transmitral and pulmonary venous flow with high accuracy
and reproducibility, using morphological and quantitative
parameters similar to those obtained by transthoracic
echocardiography, which are so familiar to general cardiol-
ogists. Therefore, the increasing role of CMR in the
assessment of the cardiovascular system requires a greater
awareness and knowledge of this condition by radiologists.
The aim of this study is to review the main mechanisms and
common causes of left ventricle diastolic dysfunction,
provide a practical approach for the assessment of LV
diastolic function and illustrate the different degrees of
diastolic dysfunction.
Keywords Cardiovascular magnetic resonance (CMR).
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Introduction
Congestive heart failure (CHF) is the third most prevalent
form of heart disease with 550,000 new cases being reported
annually [1]. CHF caused by a predominant abnormality in
diastolic function has been increasingly recognised as a
common entity and a cause of significant morbidity and
mortality, as 40–50% of the patients with heart failure may
have isolated diastolic dysfunction with a normal or near
normal left ventricle (LV) systolic function [2–4].
Moreover, in the last 2 decades, the proportion of
patients with CHF and normal LV systolic function has
increased considerably, from 38% to 54% [5].
Primary diastolic dysfunction is usually seen in patients
with hypertension, valvular heart disease and hypertrophic,
restrictive or ischaemic cardiomyopathy [6].
An early diagnosis is decisive in order to prevent
irreversible structural alterations and systolic dysfunction.
Distinguishing diastolic from systolic heart failure is crucial,
because the treatment for one may exacerbate the other, and
with proper treatment the prognosis of diastolic dysfunction
is more favourable than that of systolic dysfunction [7, 8].
Inthispaper,afterdiscussingthemechanismsandcommon
causes of LV diastolic dysfunction, we provide a practical
approachfortheassessmentofLVdiastolicfunction,focusing
on the use of phase-contrast imaging (PC) in the evaluation of
transmitral and pulmonary vein flow, and illustrate the
different degrees of diastolic dysfunction.
Mechanisms of diastolic dysfunction
Conventionally, diastole can be divided into four phases:
isovolumetric relaxation, left ventricle (LV) rapid early
filling, diastasis and LV late filling or atrial contraction [9].
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DOI 10.1007/s13244-010-0026-7Diastolic dysfunction results from myocardial relaxation
and ventricular compliance abnormalities that lead to an
increase in LVend-diastolic pressure. Myocardial relaxation
is an active or ATP-consuming process that affects the
isovolumetric relaxation phase and part of the rapid early
filling phase, while ventricular compliance is a passive
process that influences all three filling phases of diastole.
The mechanisms responsible for the abnormalities in
diastolic function can be due to factors intrinsic to the
myocardium itself (myocardial) or factors that are extrinsic
to the myocardium (extramyocardial) [3]. Myocardial
factors include changes in calcium homeostasis, energetics
(e.g., changes in the ADP/ATP ratio and ADP and
phosphate concentration), myofilaments, cytoskeleton, neu-
rohumoral and cardiac endothelial activation, as well as
increases in the content of extramyofilament cytoskeletal
proteins [3, 10].
Diastolic CHF represents the clinical entity, characterised
by signs and symptoms due to increased extravascular water
and decreased tissue/organ perfusion, in which patients with
CHF have normal or near normal systolic function and
significant diastolic dysfunction [10].
Diagnosis and parameters for the assessment of diastolic
function
Despite the high prevalence of diastolic dysfunction, the
diagnosis remains challenging, as differentiation between
systolic and diastolic CHF cannot be made based on the
clinical history, physical examination or ECG, as both have
similar changes [2], and so the diagnosis of diastolic
dysfunction requires the demonstration of elevated filling
pressures. For this reason diagnostic criteria based on
measurements of systolic and diastolic function have been
developed by The Working Group for the European Society
of Cardiology [11].
Because invasive cardiac catheterisation to demonstrate
elevated filling pressures is not feasible for routine use,
non-invasive techniques have been developed to assess
diastolic function, based on two biomechanical indices: left
ventricle (LV) relaxation and compliance, which are
inferred by measuring the transmitral inflow data with
corroborating pulmonary venous flow data [11, 12].
Transthoracic echocardiograph (TTE) is the most important
tool in the evaluation of diastolic function. Nevertheless,
this technique has some limitations: limited field of view,
cosine θ errors relative to the flow direction and an
inadequate acoustic window in approximately 15–20% of
patients [13].
Cardiovascular magnetic resonance (CMR) imaging is a
non-invasive technique that, on account of its high spatial
and temporal resolution, excellent image quality and unique
potential of three-dimensional function analysis with great
accuracy and reproducibility, is already accepted as the
"gold standard" for the assessment of LV morphology and
systolic function [14].
Recent technical developments of ECG-triggering PC-
CMR allow the routine assessment of diastolic function by
measuring the transmitral and pulmonary venous flow and
evaluating the velocity vs. time curves generated, which
reflect the filling patterns in a similar way to the methods
used in TTE [15, 16].
CMR imaging
Basics and feasibility of phase-contrast imaging
Phase-contrast CMR is a validated and accurate non-
invasive technique for the evaluation of velocity, volume
and pattern of blood flow [13, 17–24]. This technique is
based on the shift that moving spins of intravascular
protons acquire when flowing along a magnetic field
gradient relative to stationary spins, which is directly
proportional to their velocity along the direction of the
gradient, allowing velocity encoding of moving structures
and blood in any chosen direction and the calculation of
velocities of the myocardium and blood flow [15, 25, 26].
Phase-contrast sequences are able to encode the velocity
perpendicular (through-plane) or parallel (in-plane) to the
direction of flow [15, 25, 26]. Two images are reconstructed,
the magnitude "image", which provides anatomical informa-
tion, and the velocity-encoding map "image", which provides
flow information.
The value of the velocity encoding (VENC) corresponds
to the amplitude of the magnetic gradient and is given in
centimetres per second [15]. VENC is determined by the
user and establishes the highest and lowest detectable
velocity encoded; the closer it is to the maximum expected
velocity in the region of interest, the more precise the
measurement becomes [15, 25, 26]. If the VENC is set
below the peak velocity in the region of interest, aliasing or
velocity wraparound will occur [15, 25, 26].
Pressure gradients can also be calculated using the
modified Bernoulli equation: Pressure Gradient mmHg ðÞ ¼
4   Vmax
2, where Vmax is the peak velocity (m/s) [15].
The advantage of PC-CMR over TTE is that the first
quantifies the volume flow over the entire region (i.e., the
valve area) as opposed to TTE in which the flow and
velocity are assessed in a relatively small area, potentially
producing sample volume errors because the flow is not
homogeneous over such a region. Another advantage of
PC-CMR is that because of its high temporal and spatial
resolution potential, cosine θ errors can easily be avoided
and flow can be measured with a higher level of accuracy.
184 Insights Imaging (2010) 1:183–192In recent studies, PC-CMR flow measurement revealed
lower peak velocities in comparison to Doppler echocar-
diography [13, 27–31]. Nevertheless, it has been demon-
strated that the measurement of flow by PC-CMR is more
accurate than by Doppler echocardiography, as in the case
of Doppler, the flow is assessed in a relatively small
vessel area and assumes a constant velocity over the
whole vessel area, while in PC-CMR the volume flow is
evaluated over the entire vessel area, explaining why
Doppler tends to overestimate peak velocities by as much
as 25% [13, 32, 33].
How to image the transmitral flow and the pulmonary
venous flow
At our institution, all CMR examinations are performed in a
1.5-T MR unit (Achieva, Philips Healthcare, The Netherlands)
with a five-element phased array cardiac dedicated coil.
Localiser images are obtained in all three planes, and
interactive real-time images are acquired to plan the optimal
cardiac planes, specifically the LV short axis, the LV
vertical long axis, the LV horizontal long axis and LV
outflow. Cine images are obtained using ECG-triggering
steady-state sequence (balanced fast field echo) in the
different cardiac planes in order to precisely plan the mitral
valve plane. Transmitral flow data, including peak veloci-
ties and volume flow of E and Awaves, are assessed at rest
and under the Valsalva manoeuvre (performed with forced
exhalation against a closed airway) in an imaging plane
parallel to the mitral annular plane at the level of the mitral
valve leaflet tips (Fig. 1).
Right superior pulmonary venous flow data, including
peak velocities and volume flow of S, D and AR waves, are
assessed in an imaging plane perpendicular to the pulmonary
vein, 1 cm away from the junction of the pulmonary vein
with the left atrium (Fig. 2).
Patients are imaged using retrospective ECG-triggering
PC-CMR sequences in order to collect data continuously
throughout the entire cardiac cycle, acquiring 40 cardiac
phases per cycle. Technical parameters are as follows: TR
4.1 ms/TE 2.5 ms, section thickness of 10 mm, flip angle of
15° and a temporal resolution between 16 and 28 ms.
Fig. 1 PC-CMR of transmitral
inflow for assessment of
diastolic function. Cine
four-chamber (a) and LV
vertical axis (b) showing the
orientation of through-plane
PC-CMR imaging (dashed line).
(c) Magnitude and
(d) phase-contrast images are
obtained in a plane parallel to
the mitral annular plane at the
level of the mitral valve leaflet
tips. The contour of the region
of interest is drawn at the level
of the leaflet tips and includes
the whole cross-section of the
transmitral inflow (red circle).
LV, left ventricle; LA, left
atrium; RV, right ventricle; RA,
right atrium
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100 cm/s for the pulmonary vein flow. PC-CMR acquisition
times range from 8 to 15 s, depending on the heart rate.
Some limitations must be pointed out: first, as is the case
with the TTE, CMR diastolic flow indices are influenced by
arrhythmias, pressure gradients, the heart rate and the
hydration status of the patient, independent of the technique
used; second, in addition to the inadequate VENC setting
already mentioned, other sources of error in PC-CMR
measuring include motion of the imaging plane during data
acquisition due to cardiac or respiratory motion, inadequate
temporal and spatial resolution, and field heterogeneity,
which could potentially be improved by using 3D PC-CMR
[15].
Flow analysis
The PC-CMR images obtained are sent to a dedicated 3D
workstation (Philips, The Netherlands), and flow analysis is
performed by a radiologist using flow-dedicated software
(ViewForum Workstation R5.1; Philips Healthcare, The
Netherlands). The contours in the regions of interest (ROIs)
are manually drawn and automatically copied from magnitude
to velocity images and vice versa. Whenever necessary, the
R O Is h a p ea n dp o s i t i o na r ea d a p t e dt ot h er e g i o no fi n t e r e s t
for each phase of the cardiac cycle. Measurements of the
Fig. 2 PC-CMR of pulmonary
venous flow for assessment of
diastolic function. Axial (a) and
coronal (b) survey demonstrat-
ing the orientation of through-
plane PC-CMR imaging (dashed
line). (c) Magnitude and (d)
phase-contrast images are
obtained in a plane perpendicu-
lar to the right superior pulmo-
nary vein (arrow), 1 cm away
from the junction of the pulmo-
nary vein with the left atrium.
RPA, right pulmonary artery;
RPV, right superior pulmonary
venous
Fig. 3 Normal transmitral inflow pattern. E, initial rapid early flow;
A, late or atrial flow
186 Insights Imaging (2010) 1:183–192transmitral inflow yielding information on E and Awaves and
on pulmonary venous flow and peak velocities of S, D and
AR waves are displayed on a velocity or flow vs. time graph.
The peak velocity ratio of the E and A waves, called the E/A
ratio, is calculated. The deceleration time (DT) is also
calculated using the method described by Appleton et al. [34].
Normal transmitral and pulmonary venous flow pattern
The normal transmitral inflow curve is characterised by an
initial rapid early flow (E wave) and a late or atrial flow (A
wave). As the E wave is higher than the Awave (E>A), the
E/A ratio is greater than 1 (Fig. 3).
The normal pulmonary venous flow curve consists of
one or two systolic peaks and one diastolic peak, with
equivalent flow velocities, plus a reversed flow in end
diastole (Fig. 4).
The systolic (S) flow corresponds to flow into the left
atrium (LA) during ventricular systole and consists of
one or two peaks; the first systolic peak (S1) is caused
by the reduction of the LA pressure due to LA relaxation
and longitudinal LV shortening with subsequent motion
of the annulus of the atrioventricular valve, and the
second systolic peak (S2) reflects right ventricular stroke
volume and atrial compliance. The diastolic (D) flow
represents the reduction of the LA pressure during
ventricular filling in early diastole. The reversed flow is
caused by atrial contraction and is called atrial reversed
Fig. 4 Normal pulmonary venous inflow pattern. S1, first systolic
peak; S2, second systolic peak; D, diastolic flow; AR, atrial reversed
Fig. 5 Classification of diastolic dysfunction grades (I–IV)
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0.30 cm/s.
Diastolic dysfunction patterns
Diastolic dysfunction can be classified in four grades [35]
(Fig. 5).
In grade I there is an abnormal relaxation, which is
characterised by a transmitral inflow pattern with an A
wave higher than the E wave (E<A) and an E/A ratio less
than 1; prolonged deceleration time (DT) is commonly
associated (Fig. 6).
As LV relaxation becomes further compromised and the
LV telediastolic pressure increases, the contribution of atrial
contraction to the LV filling is once again reduced, resulting
in a transmitral inflow pattern similar to normal, as the E
wave is again higher than the A wave (E>A), and the E/A
ratio becomes greater than 1. This transmitral inflow pattern
is termed pseudo-normal or grade II (Fig. 7).
The Valsalva manoeuvre reduces preload and, in patients
with normal diastolic function, produces similar reductions
in the peak velocities of the E and Awaves, so the E/A ratio
will continue to be greater than 1.
However, in patients with diastolic dysfunction grade II
or pseudo-normal pattern, with the Valsalva manoeuvre the
pseudo-normal pattern becomes an abnormal relaxation
pattern or grade I, and so the E/A ratio will be less than 1,
allowing differentiation from the normal pattern.
The assessment of pulmonary venous flow is also useful
in differentiating a pseudo-normal pattern from a normal
pattern. In the case of a pseudo-normal pattern, the systolic
wave is smaller than the diastolic wave (S<D), and the AR
wave velocity is usually greater than 0.30 cm/s. As well as
the tissue Doppler, tissue PC-CMR, which can improve
the assessment of diastolic function and be particularly
useful in assessing pseudo-normalisation, is now also
available. However, tissue PC-CMR or myocardial
velocity mapping cannot yet be feasibly adopted in the
clinical setting because of its limited spatial and temporal
resolution [25].
Finally, the increasing ventricular stiffness leads to a
restrictive pattern, which is divided into reversible (grade III)
and irreversible (grade IV), and is characterised by a further
increase in E wave (E>>A) with a decrease in DT due to
flow into the non-compliant ventricle and a pulmonary
venous flow pattern showing an S wave robustly lower than
the D wave (S<<D) and an AR wave velocity greater than
0.30 cm/s (Fig. 8). The Valsalva manoeuvre is also very
helpful in distinguishing a reversible restrictive pattern
(grade III) from an irreversible (grade IV) one, because with
this manoeuvre the reversible restrictive pattern can turn into
an abnormal relaxation pattern, whereas the irreversible
restrictive pattern remains unchanged. A restrictive pattern
is associated with poor prognosis, with patients often
presenting symptoms and signs of CHF, and is characteristic
of restrictive cardiomyopathies and dilated cardiomyopathy
with poor LV systolic function.
Common causes of diastolic dysfunction
Several cardiovascular and systemic diseases can cause LV
diastolic dysfunction, as it is the most common hypertensive,
ischaemic and hypertrophic cardiomyopathy (Table 1).
Long-standing pressure overload, such as in systemic
Fig. 6 A 63-year-old woman with a long-standing history of
hypertension and normal systolic function. (a) Transmitral inflow
analysis shows an E wave (E) lower than the A wave (A) and an E/A
ratio <1 due to reduced LV filling in early diastole indicating a grade I
diastolic dysfunction (abnormal LV relaxation). (b) Pulmonary venous
flow analysis demonstrates a systolic flow peak (S) higher than the
diastolic (D) with normal reversed flow (AR)
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LV hypertrophy in order to normalise myocardial wall
tension. Nevertheless, diastolic dysfunction can occur even
in the absence of LV hypertrophy because of subnormal
high-energy phosphate metabolism [6]. For that reason, LV
diastolic dysfunction can be found in only 25% of
asymptomatic hypertensive patients without LV hypertrophy
but in 90% of those with LV hypertrophy [6].
Ischaemic cardiomyopathy is also a common cause of
diastolic dysfunction and is found in approximately 60% of
all patients with acute myocardial infarction [6]. This
results from several mechanisms, such as calcium overload
of the myocytes with prolonged and incomplete relaxation,
LV asynchrony, papillary muscle dysfunction with valvular
incompetence, LV myocardial stunning, hibernation and
post-infarction remodelling [6, 16]. Hypertrophic cardio-
myopathy is considered the prototype for diastolic heart
failure. Relaxation abnormalities in hypertrophic hearts are
due to altered myocardial high-energy phosphate metabo-
lism and changes in the passive elastic properties of the
myocardium, such as non-uniform myocardial hypertrophy
and fibrosis [6, 16].
In patients with infiltrative cardiomyopathies, diastolic
dysfunction is commonly the primary myocardial disorder
and is characterised by increased LV wall thickness and
reduced LV compliance, often evolving to a restrictive
pattern.
Prognosis of diastolic dysfunction
Several studies have demonstrated the high morbidity
associated with diastolic dysfunction, resulting in frequent
hospital admissions with a 1-year readmission rate of close
to 50% in patients with diastolic CHF [36–41], which is
comparable to that of patients with systolic CHF [2]. The
mortality rate after 5 years is 68% in patients with diastolic
CHF compared with 82% of patients with systolic CHF
[42].
However, any degree of diastolic dysfunction is an
important prognostic factor, and it has been demonstrated
that in hypertensive patients the abnormal relaxation is
associated with an increased risk of cardiovascular events
and mortality [42].
 Fig. 7 A 50-year-old man with ischaemic cardiomyopathy and
preserved systolic function. (a) Transmitral inflow analysis demon-
strates an E wave (E) higher than the Awave (A) and an E/A ratio >1.
However, with the Valsalva manoeuvre (b) the E wave becomes lower
than an A wave and an E/A ratio <1 indicates grade II diastolic
dysfunction or pseudo-normal pattern. (c) Pulmonary venous flow
analysis shows a diastolic flow peak (D) higher than the systolic (S)
with a prominent reversed flow (AR) indicative of an increase in the
left atrial filling pressures
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In clinical practice, diastolic dysfunction is a common entity,
especially in patients with hypertension and ischaemic
cardiomyopathy, and it is the predominant cause of CHF in
40–50% of patients.
Cardiovascular magnetic resonance imaging is considered
the "gold standard" for evaluating the morphology and LV
systolic function, and is widely used in the evaluation of
several cardiovascular and systemic diseases. As the pres-
ence of diastolic dysfunction is associated with a poor
prognostic factor, we consider it important to include the
systematic assessment of diastolic function as part of the
routine protocol of many diseases, such as in patients with
CHF and normal LV ejection fraction, ischaemia, hyperten-
sion, hypertrophy or infiltrative cardiomyopathy. In this
group of patients the routine assessment of diastolic function
by CMR using PC-CMR allows the evaluation of LV filling
Fig. 8 A 51-year-old man with myocardial iron overload due to
haemochromatosis and preserved systolic function. (a) Transmitral
inflow analysis shows a prominent E wave (E) and an Awave (A) that
is nearly imperceptible (E/A ratio>1.5). (b) The mitral flow pattern
does not change significantly with the Valsalva manoeuvre. (c)
Pulmonary venous flow analysis demonstrates a diastolic flow peak
(D) that is notably higher than the systolic (S) with a prominent
reversed flow (AR) indicating high left atrial filling pressures
Table 1 Causes of diastolic dysfunction
Common causes
Ischaemic cardiomyopathy
Systemic hypertension
Hypertrophic cardiomyopathy
Aortic valve stenosis
Other causes
Infiltrative cardiomyopathies
Amyloidosis
Sarcoidosis
Iron overload cardiomyopathy (primary or secondary)
Other storage diseases
Glycogen storage disease
Anderson-Fabry disease
Mucopolysaccharidosis
Fibroplastic cardiomyopathies
Endomyocardial fibrosis
Endocardial fibroelastosis
Loffler's fibroplastic endocarditis
Pericardial disorders
Constrictive pericarditis
Pericardial effusion and tamponade
190 Insights Imaging (2010) 1:183–192patterns, with only a couple of minutes added to a standard
CMR examination time, providing a more comprehensive
clinical evaluation of the LV in addition to LV systolic
function assessment. Thus, the diastolic function can be
accurate and easily evaluated using morphological and
quantitative parameters similar to those obtained by TTE,
which are so familiar to general cardiologists. Therefore, the
increasing role of CMR in the assessment of the cardiovas-
cular system requires a greater awareness and knowledge of
this condition by radiologists.
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